Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Behar, K. L.
Right arrow Articles by Rothman, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Behar, K. L.
Right arrow Articles by Rothman, D. L.
(Journal of Nutrition. 2001;131:2498S-2504S.)
© 2001 The American Society for Nutritional Sciences


Supplement

In Vivo Nuclear Magnetic Resonance Studies of Glutamate-{gamma}-Aminobutyric Acid-Glutamine Cycling in Rodent and Human Cortex: the Central Role of Glutamine1 ,2

Kevin L. Behar*3 and Douglas L. Rothman{dagger}

Departments of * Psychiatry and {dagger} Diagnostic Radiology, Magnetic Resonance Center for Research in Metabolism and Physiology, Yale University School of Medicine, New Haven, CT 06520

3To whom correspondence should be addressed. E-mail: Kevin.behar{at}yale.edu.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 The glutamate-glutamine cycle:...
 Specialized transporters clear...
 Glutamine transporters mediate...
 In vivo NMR studies...
 Development of a quantitative...
 Measurements of glutamine...
 The rate of glutamine...
 CONCLUSIONS
 LITERATURE CITED
 
It has been recognized for many years that the metabolism of brain glutamate and {gamma}-aminobutyric acid (GABA), the major excitatory and inhibitory neurotransmitters, is linked to a substrate cycle between neurons and astrocytes involving glutamine. However, the quantitative significance of these fluxes in vivo was not known. Recent in vivo 13C and 15N NMR studies in rodents and 13C NMR in humans indicate that glutamine synthesis is substantial and that the total glutamate-GABA-glutamine cycling flux, necessary to replenish neurotransmitter glutamate and GABA, accounts for >80% of net glutamine synthesis. In studies of the rodent cortex, a linear relationship exists between the rate of glucose oxidation and total glutamate-GABA-glutamine cycling flux over a large range of cortical electrical activity. The molar stoichiometric relationship (~1:1) found between these fluxes suggests that they share a common mechanism and that the glutamate-GABA-glutamine cycle is coupled to a major fraction of cortical glucose utilization. Thus, glutamine appears to play a central role in the normal functional energetics of the cerebral cortex.


KEY WORDS: • glutamine • glutamate-glutamine cycle • neuron • astrocyte trafficking • NMR • cerebral glucose utilization


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 The glutamate-glutamine cycle:...
 Specialized transporters clear...
 Glutamine transporters mediate...
 In vivo NMR studies...
 Development of a quantitative...
 Measurements of glutamine...
 The rate of glutamine...
 CONCLUSIONS
 LITERATURE CITED
 
In the central nervous system, glutamine synthesis occurs exclusively in the astroglia from glutamate and ammonia. Glutamine plays major roles in nitrogen and carbon homeostasis, in detoxification of ammonia and as a precursor for the synthesis of neurotransmitter glutamate and {gamma}-aminobutyric acid (GABA)4 in specialized excitatory and inhibitory neurons. The existence of carbon cycles involving glutamate, GABA and glutamine have been recognized for nearly 30 years, although the quantitative significance of these pathways in relation to glucose metabolism and neuronal energetics is not known.

The development and application of nuclear magnetic resonance (NMR) spectroscopy to studies of the brain has permitted carbon and nitrogen metabolism to be assessed in vitro and in vivo using 13C and 15N isotopically labeled substrates (Badar-Goffer et al. 1990 and 1992Citation Citation , Cerdán et al. 1990Citation , Fitzpatrick et al. 1990Citation , Gruetter et al. 1994 and 1998Citation Citation ), Kanamori and Ross 1993Citation , Rothman et al. 1985Citation , Shank et al. 1993Citation , Shen et al. 1998 and 1999Citation Citation , Sibson et al. 1997, 1998a and 1998bCitation Citation Citation ; [see reviews by Bachelard (1998)Citation , Cruz and Cerdán (1999)Citation , Rothman et al. (1999)Citation and Westergaard et al. (1995)Citation ]. 13C and 15N NMR have become major tools with which to study brain energy metabolism and substrate trafficking between neurons and astrocytes.

Until recently, the contribution of glutamate and GABA neurotransmitter cycling to glutamine synthesis was thought to represent a smaller fraction of its total synthesis, with the majority associated with ammonia detoxification. However, measurements of the fluxes of glutamine synthesis, glutamate-glutamine cycling and glucose oxidation in vivo using 13C NMR have revealed the glutamate-glutamine cycle to constitute a large flux, far greater than that associated with detoxification under physiologic conditions. Perhaps of greater significance, these studies provide evidence that the glutamate-glutamine neurotransmitter cycle and glucose utilization are functionally coupled. The new findings both support and extend a recent proposal in which glutamate release and its sodium-dependent uptake by astrocytes couples astroglial glucose utilization to glutamatergic neuronal activity (Pellerin and Magistretti 1994Citation ).

The present article describes the biochemical and molecular basis for the glutamate-GABA-glutamine cycle and evidence from recent in vivo 13C and 15N NMR studies conducted in our laboratory that this cycle plays a central role in brain glucose metabolism.


    The glutamate-glutamine cycle: biochemical and molecular considerations
 TOP
 ABSTRACT
 INTRODUCTION
 The glutamate-glutamine cycle:...
 Specialized transporters clear...
 Glutamine transporters mediate...
 In vivo NMR studies...
 Development of a quantitative...
 Measurements of glutamine...
 The rate of glutamine...
 CONCLUSIONS
 LITERATURE CITED
 
The metabolism of neurotransmitter glutamate and GABA is linked to a substrate cycle between neurons and astrocytes involving glutamate, GABA and glutamine (Martin 1995Citation , Schousboe et al. 1993Citation , Van den Berg 1972Citation ). The efficient functioning of the glutamate-glutamine cycle is made possible by the physical segregation of specific enzymes between neurons and glia and the presence of specialized amino acid transporter proteins. Glutamate and GABA released into the synapse in response to nerve terminal depolarization, bind to their respective receptors and are cleared from the interstitum by uptake into astroglia. Within astroglia, glutamate (and GABA through an indirect process) is converted to glutamine by the astroglia-specific enzyme, glutamine synthetase (GS) (Martinez-Hernandez et al. 1977Citation ). Glutamine is transported from astroglia into neurons and is hydrolyzed to glutamate by the mitochondrial enzyme, phosphate-activated glutaminase (PAG) (Kanamori and Ross 1995Citation , Kvamme and Lenda 1982Citation ). Thus, this pathway results in a cyclic flow of carbon between nerve terminals and glia, i.e., a glutamate-GABA-glutamine cycle. Some of the key molecular components required for the operation of this cycle are described below.


    Specialized transporters clear interstitial glutamate and GABA during synaptic activity
 TOP
 ABSTRACT
 INTRODUCTION
 The glutamate-glutamine cycle:...
 Specialized transporters clear...
 Glutamine transporters mediate...
 In vivo NMR studies...
 Development of a quantitative...
 Measurements of glutamine...
 The rate of glutamine...
 CONCLUSIONS
 LITERATURE CITED
 
Glutamate transport.

The rapid clearance of transmitter glutamate from the synapse is accomplished by the Na+-dependent, high affinity, glutamate transporter proteins. Three glutamate transporters (GLT) have been identified in the cerebrum, the astroglial transporters, glutamate-aspartate transporter and GLT1 [or their human homologs, excitatory amino acid transporters (EAAT)1 and EAAT2, respectively], and the neuronal transporter, excitatory amino acid carrier (EAAC)1/EAAT3 (Chaudhry et al. 1995Citation , Kanai and Hediger 1992Citation , Rothstein et al. 1994 and 1996Citation Citation ). Two other neuronal transporters, EAAT4 and EAAT5, are expressed on cerebellar GABAergic Purkinje cells and in the retina, respectively, and appear to differ from their cortical counterparts in gating Cl- ions (Arriza et al. 1997Citation , Fairman et al. 1995Citation , Yamada et al. 1996Citation ). Although the functions of the neuronal transporters are not yet clear, one of them (EAAC1) is expressed on some GABAergic nerve terminals (Kanai and Hediger 1992Citation , Rothstein et al. 1994 and 1996Citation Citation ) where it may have a role in the supply of precursor glutamate for GABA synthesis (Sepkuty et al. 2000Citation ).

Evidence from molecular (Rothstein et al. 1996 and 1994Citation Citation ) and electrophysiologic studies (Bergles and Jahr 1997 and 1998Citation Citation ) indicates that the astroglial transporters clear the majority of glutamate from the synaptic cleft. As discussed subsequently, the molecular findings are consistent with in vivo NMR study results showing that glutamate uptake into astroglia and its conversion to glutamine is the predominant path for recycling of neuronal glutamate in vivo (Rothman et al. 1999Citation ).

Glutamate transport is electrogenic and driven by the electrochemical potential gradients of Na+, K+ and H+. Studies of the stoichiometry of GLT1 show glutamate uptake to be coupled to cotransport of 3 Na+ and 1 H+ and countertransport of 1 K+ (Levy et al. 1998Citation ). The cotransport of Na+ with glutamate has been reported to stimulate Na+/K+-ATPase and glucose utilization in cultured astrocytes (Pellerin and Magistretti 1994Citation , Sokoloff et al. 1996Citation ). As explained below, an extension of this molecular mechanism has been proposed to explain the 1:1 flux stoichiometry discovered between cortical glucose oxidation and glutamate-glutamine cycling.

GABA transport.

Astroglia and neurons possess a high capacity for the transport of GABA (Henn and Hamberger 1971Citation , Hertz et al. 1978Citation , Ryan and Roskoski 1977Citation ). Molecular cloning studies have identified four high affinity, Na+ and Cl--dependent, GABA transporters (GAT) in the brain (GAT1, GAT2, GAT3, GAT4/BGT-1). With the exception of GAT-3, which is expressed on astrocytes, the other GAT subtypes are expressed on both neurons and astrocytes (Minelli et al. 1995 and 1996Citation Citation , Ribak et al. 1996Citation ). The functional roles of the different GABA transporter subtypes in the clearance of GABA from synaptic, and possibly extrasynaptic sites remain to be elucidated. Rapid metabolism of GABA in astrocytes via an active GABA-transaminase (Chan-Palay et al. 1979Citation , Larsson and Schousboe 1990Citation ) maintains GABA at a low level in these cells, resulting in a large concentration gradient between GABAergic neurons and the surrounding transporter-rich astroglia. GABA synthesis depends on glutamine for its supply of glutamate precursors in vitro and in vivo (Balazs et al. 1973Citation , Patel et al. 2000Citation , Sonnewald et al. 1993Citation , Van den Berg 1972Citation ), indicating that some fraction of GABA released from GABAergic neurons is not recycled directly back into the terminal. Thus, it appears likely that astroglial uptake could be as important for GABA as it is for glutamate.

Astroglial metabolism of extracellular glutamate and GABA stimulates glutamine synthesis.

Glutamine synthesis in astroglia is generally considered the major net metabolic pathway for the metabolism of extracellular glutamate (Wanienski and Martin 1986Citation ). GABA metabolism in astroglia can also lead to glutamine synthesis. Unlike glutamate, however, GABA must be further processed in the astroglial tricarboxylic acid (TCA) cycle, a two-step reaction involving {alpha}-ketoglutarate and NAD+ that converts GABA to succinic acid via GABA-transaminase (GABA-T) and succinic semialdehyde dehydrogenase. The initial transamination between GABA and {alpha}-ketoglutarate catalyzed by GABA-T produces glutamate, which may then proceed to formation of glutamine.

Glutamine is not the only pathway for the metabolism of extracellular glutamate in astroglia. Significant oxidation of extracellular glutamate was reported by Yu et al. (1982)Citation in cultured astrocytes although McKenna et al. (1996)Citation showed this process to be dependent on the concentration of extracellular glutamate. Net oxidation of glutamate and GABA carbon can occur in astrocytes through the pyruvate recycling pathway, which involves malic enzyme (Cruz et al. 1998Citation , Haberg et al. 1998Citation , McKenna et al. 1995Citation ). In the study of McKenna et al. (1996)Citation , oxidation was significant for extracellular glutamate levels above ~100 µmol/L, which is far greater than estimated normal levels (Levy et al. 1998Citation ), and within the range considered to be excitotoxic (Choi et al. 1987Citation ). Thus, glutamate oxidation may be of pathophysiologic significance when neuronal release exceeds uptake (e.g., ischemia or epileptic seizures). Evidence for oxidation of glutamate and GABA after transient ischemia in vivo has been reported (Pascual et al. 1998Citation ). Pyruvate recycling and malic enzyme may play an important role in the generation of NADPH to maintain reduced glutathione (Vogel et al. 1999Citation ), which is highly concentrated in astroglia. Glutathione has been shown to protect glia against free radical damage associated with glutamate excitotoxicity (Chen et al. 2000Citation ). As discussed subsequently, results of 13C and 15N NMR studies of rat and human cerebral cortex indicate that under normal physiologic conditions, glutamine synthesis is favored by far over oxidation (and anaplerosis) as the major pathway of glutamate neurotransmitter recycling.


    Glutamine transporters mediate the flow of glutamine from astrocytes to neurons
 TOP
 ABSTRACT
 INTRODUCTION
 The glutamate-glutamine cycle:...
 Specialized transporters clear...
 Glutamine transporters mediate...
 In vivo NMR studies...
 Development of a quantitative...
 Measurements of glutamine...
 The rate of glutamine...
 CONCLUSIONS
 LITERATURE CITED
 
Glutamine produced from exogenous glutamate is readily released by cultured astrocytes (Wanienski and Martin 1986Citation ) where it serves as a major precursor of the releasable pool of glutamate and GABA in nerve terminal preparations (Sonnewald et al. 1993Citation , Szerb and O’Regan 1985Citation ). Until recently, little was known specifically about glutamine transport in neurons and glia. Cloning studies have begun to reveal the molecular properties of the major glutamine transporters expressed in brain cells. Specific Na+- and H+-dependent astroglial [SN1; (Chaudhry et al. 1999Citation ) and ASCT2; (Broer et al. 1999Citation )] and neuronal [GlnT/SAT1 and SAT2; (Varoqui et al. 2000Citation ), (Yao et al. 2000Citation )] glutamine transporters have been described with differing substrate dependencies. Differences reported in the kinetic properties between the specific glutamine transporters favor the efflux of glutamine from astroglia and its influx into neurons, providing for efficient operation of the glutamate-glutamine cycle.

Glutamine is a precursor for the resynthesis of neuronal glutamate and GABA.

Mature neurons do not contain the necessary anaplerotic enzymes to resynthesize glutamate and GABA lost during neurotransmission and depend on astrocytes to supply the needed carbon (Cooper and Plum 1987Citation , Kaufman and Driscoll 1993Citation , Martin 1995Citation ). Phosphate-activated glutaminase (PAG) is a mitochondrial enzyme, present mainly in neurons but also reported in glia (Hogstad et al. 1988Citation , Wiesinger 1995Citation ), which converts glutamine to glutamate and ammonia. Highly enriched in glutamatergic and GABAergic neurons, PAG provides an important pathway to replenish neurotransmitter stores of glutamate and GABA from glutamine. Addition of isotopically labeled glutamine to isolated nerve terminals, neuronal cell cultures, brain slices and in vivo results in labeling of both cellular and extracellular glutamate (Sonnewald et al. 1993Citation , Wanienski and Martin 1986Citation , Ward et al. 1983Citation ). Application of 6-diazo-5-oxo-L-norleucine, a potent and selective inhibitor of PAG, to the rat cortex in vivo results in a rapid (<30 min) but reversible loss of glutamate immunostaining in pyramidal cell bodies and dendrites, which returns over the course of several days (Conti and Minelli 1994Citation ). In vitro studies have shown that in addition to glutamine, malate and {alpha}-ketoglutarate may serve as carbon sources for repletion of neuronal glutamate and GABA (Peng et al. 1993Citation , Shank and Campbell 1984Citation ). However, as described subsequently, results of in vivo NMR studies of the rat and human cortex suggest that glutamine is the major precursor of neuronal glutamate and possibly GABA as well.


    In vivo NMR studies of the role of glutamine in the glutamate-glutamine cycle
 TOP
 ABSTRACT
 INTRODUCTION
 The glutamate-glutamine cycle:...
 Specialized transporters clear...
 Glutamine transporters mediate...
 In vivo NMR studies...
 Development of a quantitative...
 Measurements of glutamine...
 The rate of glutamine...
 CONCLUSIONS
 LITERATURE CITED
 
Although there is little disagreement about the existence of the glutamate-glutamine cycle, the significance of this cycle in relation to brain energetics and function has been controversial due mainly to the paucity of quantitative flux information. The development of quantitative noninvasive NMR techniques to measure the fluxes associated with brain glucose and glutamate metabolism has begun to fill this knowledge gap and in the process reveal new insights into the coupling between metabolism and function. As described subsequently, research findings from our laboratory using in vivo 13C and 15N NMR suggest that in the cerebral cortex, the glutamate-GABA-glutamine cycle is a major flux and it is tightly coupled to the oxidation of glucose.


    Development of a quantitative approach to interpret glutamine metabolism in terms of glutamate neurotransmitter cycling and de novo (anaplerotic) synthesis
 TOP
 ABSTRACT
 INTRODUCTION
 The glutamate-glutamine cycle:...
 Specialized transporters clear...
 Glutamine transporters mediate...
 In vivo NMR studies...
 Development of a quantitative...
 Measurements of glutamine...
 The rate of glutamine...
 CONCLUSIONS
 LITERATURE CITED
 
Glutamine synthesis in astroglia reflects the sum of the fluxes of glutamate (and GABA) neurotransmitter cycling and de novo glutamine synthesis to fix excess ammonia in the process of ammonia detoxification. As shown in a diagram depicting these flows (Fig. 1Citation ), unique determination of the glutamate-glutamine cycling flux requires knowledge of the rate of de novo glutamine synthesis, which is related tothe anaplerotic flux. Employing a constrained kinetic model of glutamate-glutamine cycling (Shen et al. 1998Citation , Sibson et al. 1997 and 1998bCitation Citation ) in which carbon and nitrogen are balanced for all metabolite pools at steady state, it is possible to derive quantitative testable predictions about the relationships among fluxes associated with glutamine synthesis (Vgln), ammonia nitrogen transport (Vtrans and Vefflux) and anaplerosis (Vana). As discussed above, glutamine is the major carrier of ammonia nitrogen from the brain (Cooper and Plum 1987Citation ). Under steady-state conditions in which all metabolite levels and fluxes are constant, the rate of glutamine efflux from the brain must be compensated by de novo (anaplerotic) synthesis of glutamine. The anaplerotic synthesis of glutamine carbon, which can occur only in the astroglia, initially involves carbon dioxide fixation of glucose-derived pyruvate to oxaloacetate (at the rate VCO2) via the astroglia-specific enzyme, pyruvate carboxylase (PC). The subsequent conversion of oxaloacetate to {alpha}-ketoglutarate in the astroglial TCA cycle, followed by synthesis of glutamate either by glutamate dehydrogenase (GDH) or transamination, and the synthesis of glutamine by GS complete this pathway (Vana). Thus, at steady state, glutamine efflux must be balanced by anaplerotic glutamine synthesis. For each carbon skeleton of glutamine formed through anaplerosis, between 1 and 2 nitrogen atoms can be removed, depending on the relative rates of GDH and transamination. Thus, as described in Sibson et al. (1997)Citation , balanced carbon and nitrogen flows lead to the following relationships among the fluxes:

(1)


(2)

Thus, Vcycle can be derived from a measurement of glutamine synthesis if one of the other fluxes is either known or can be measured.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 1. Schematic representation of the glutamate-glutamine cycle between neurons and astrocytes. (A) Depiction of glutamine synthesis from glutamate neurotransmitter cycling only. Glutamate is released from neurons and is transported into astrocytes at the rate, Vcycle, and combines with ammonia to form glutamine at the rate, Vgln. Glutamine is released from the astrocyte and transported into neurons at the rate, Vcycle, and is hydrolyzed to glutamate completing the cycle. (B) Depiction of glutamine synthesis as the sum of glutamate neurotransmitter cycling and ammonia detoxification. Same as in (A) but now includes the rates of net ammonia transport into the astrocytes from blood (Vtrans) and anaplerotic glutamine synthesis (Vana) from glucose (Glc). Solution of the differential equations describing these flows at steady state constrained by mass and isotope balance as described in the text permits the individual fluxes to be determined. An alternate model involving the cycling of {alpha}-ketoglutarate (not shown) was found to be incompatible with enrichment time courses obtained from [2-13C]glucose (Sibson et al. 2001Citation ). [From Sibson et al. (1998b)Citation , with permission from S. Karger AG, Basel, Switzerland.]

 

    Measurements of glutamine synthesis during hyper- and normoammonemia: experimental validation of a model of glutamate-glutamine cycling
 TOP
 ABSTRACT
 INTRODUCTION
 The glutamate-glutamine cycle:...
 Specialized transporters clear...
 Glutamine transporters mediate...
 In vivo NMR studies...
 Development of a quantitative...
 Measurements of glutamine...
 The rate of glutamine...
 CONCLUSIONS
 LITERATURE CITED
 
In vivo 13C NMR measurements using [1-13C] and [2-13C]glucose.

Glutamine levels increase throughout the brain during hyperammonemia (Cooper and Plum 1987Citation ). Under appropriate experimental conditions, hyperammonemia can be used to test the validity of relationships predicted by the metabolic model. After a prolonged infusion of ammonium acetate in rats, a metabolic steady state can be achieved in which the glutamine level and rate of synthesis (Vgln), although elevated, remain constant. In the absence of changes in Vcycle the increase in Vgln with hyperammonemia would be predicted by Equation (2) to equal the increase in de novo (anaplerotic) glutamine synthesis ({Delta}Vana) and glutamine efflux ({Delta}Vefflux).

Steady-state values of VTCA and Vgln were determined for the cortex of hyperammonemic and control rats using 13C NMR (Sibson et al. 1997Citation ). The enrichment time courses of glutamine and glutamate were measured during an infusion of [1-13C]glucose (Fig. 2Citation ), and the two fluxes were evaluated from the best fit of the metabolic model to the enrichment data. VTCA was not significantly different from control [0.57 ± 0.16 vs. 0.46 ± 0.12 µmol/(g · min)], whereas Vgln was increased by 0.11 ± 0.07 µmol/(g · min). The comparable increase [~0.1 µmol/(g · min)] in Vana and Vefflux predicted on the basis of Equations (1) and (2) is consistent with published reports of these fluxes measured in hyperammonemic animals using 14C isotopes and arteriovenous differences (Dejong et al. 1992Citation , Waelsch et al. 1964Citation ).



View larger version (34K):
[in this window]
[in a new window]
 
Figure 2. In vivo 13C nuclear magnetic resonance (NMR) time courses of glutamate and glutamine labeling in the rat cortex during an intravenous infusion of [1-13C]glucose in anesthetized control and hyperammonemic rats. A steady-state hyperammonemic condition (constant and elevated levels of blood ammonia and brain glutamine) was established in the blood before the labeled isotope infusion began. [From Sibson et al. (1997)Citation , Copyright 1997 National Academy of Sciences, U.S.A., with permission.]

 
Measurements of the contribution of anaplerosis to glutamine synthesis using [2-13C] glucose have confirmed the essential features of the glutamate-glutamine cycling model. [2-13C] glucose is metabolized to [2-13C]pyruvate by the glycolytic pathway of neurons and astroglia. Entry of [2-13C] pyruvate into the TCA cycle via pyruvate dehydrogenase (PDH) leads to the labeling of glutamate C5 and loss of the label as CO2. In addition to PDH, astroglia possess an alternate pathway for the metabolism of pyruvate. In these cells [2-13C] pyruvate may enter the astroglial TCA cycle through CO2 fixation catalyzed by pyruvate carboxylase, resulting in labeling of C3, C2 and C1 of astroglial glutamate and glutamine. The steady-state rates of anaplerotic glutamine synthesis (Vana) and glutamate-glutamine neurotransmitter cycling (Vcycle) during hyperammonemia were determined from the best fit of the metabolic model to the time courses of C3 and C2 isotopic labeling of glutamine and glutamate. The close correspondence between the predicted [0.1 µmol/(g · min)] and measured [0.09–0.10 µmol/(g · min)] values of Vana and the measured values of Vcycle using either [1-13C]glucose or [2-13C]glucose (Sibson et al. 2001Citation ) lends strong support for the current metabolic model. During hyperammonemia, anaplerosis contributed ~32% of the glutamine synthesis flux but only 17–23% under physiologic conditions in the cortex of anesthetized adult rats (Sibson et al. 2001Citation ). Thus, Vcycle represents the larger component of glutamine synthesis. Quantitation of glutamate and glutamine fluxes in the conscious human occipital cortex after infusions of [1-13C]glucose (Shen et al. 1999Citation ) and more recently, [2-13C]glucose (Mason et al. 2000Citation ), indicates that Vcycle constitutes the major fraction (80–90%) of total glutamine synthesis. In contrast to the results cited above, Gruetter et al. (1998)Citation reported a somewhat higher value of anaplerosis in human brain, although Vcycle still accounted for a majority (70–85%) of glutamine synthesis.

In vivo 15N NMR measurements of acute hyperammonemia.

Nitrogen metabolism can be assessed directly in the brain using 15N-labeled substrates and 15N NMR in vitro and in vivo (Kanamori and Ross 1993 and 1995Citation Citation , Shen et al. 1998Citation ). Incorporation of 15N-labeled ammonia into glutamine N5 is a direct measure of the flux through glutamine synthetase, whereas isotopic labeling of (glutamate + glutamine) N2 reflects sequential flow through glutamate dehydrogenase (GDH) and GS. The flux of ammonia transported into the brain and fixed as glutamine (Vtrans) was estimated from the sum of 15N labeling of N5 (glutamine) and N2 (glutamate + glutamine), which represented the major 15N-labeled resonances detected in the spectra (Fig. 3Citation ). The ammonia transport flux determined in the 15N NMR experiment, Vtrans = 0.13 ± 0.02 µmol/(g · min), may be related to anaplerotic glutamine synthesis through the 1:2 stoichiometric relationship of their fluxes (i.e., {Delta}Vana = 0.5 {Delta}Vtrans). The value reported for Vana of 0.065 µmol/(g · min) is somewhat lower than that given in the [2-13C]glucose experiment and can be ascribed to the observed delay (~1 h) in the labeling of glutamine N2 compared with N5 (Shen et al. 1998Citation ). This lag may reflect either a delay in the stimulation of anaplerosis and/or an inflow of unlabeled N2 nitrogen from transamination with branched-chain amino acids (Yudkoff 1997Citation ). A close correspondence was found between the initial rate of glutamine synthesis (when anaplerosis flux is low) during acute hyperammonemia using 15N NMR [0.20 ± 0.06 µmol/(g · min); Shen et al. 1998Citation ] and 13C NMR using [1-13C]glucose [0.21 ± 0.04 µmol/(g · min); Sibson et al. 1997Citation ]. Thus, the results of the nonsteady-state 15N NMR study indicate that even under conditions of acute hyperammonemia, anaplerosis represents a smaller fraction (in this case, approximately one third) of total glutamine synthesis with the larger fraction (approximately two thirds) contributed by glutamate neurotransmitter recycling. Under normal physiologic conditions in which blood ammonia levels are low, glutamate neurotransmitter recycling represents >80% of glutamine synthesis.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 3. In vivo time course of [5-15N]glutamine and [2-15N]glutamine + glutamate labeling during an infusion of 15NH3 using 15N nuclear magnetic resonance (NMR) spectroscopy. Labeling of the N2 resonances lags behind that of the N5. The net rate of ammonia transport can be determined by fitting the glutamate-glutamine cycling model to the sum of both resonances (N2 + N5). [Fig. 3Citation A from Shen et al. (1998)Citation , with permission from S. Karger AG, Basel, Switzerland].

 

    The rate of glutamine synthesis is proportional to electrical and metabolic activity supporting a direct link to function
 TOP
 ABSTRACT
 INTRODUCTION
 The glutamate-glutamine cycle:...
 Specialized transporters clear...
 Glutamine transporters mediate...
 In vivo NMR studies...
 Development of a quantitative...
 Measurements of glutamine...
 The rate of glutamine...
 CONCLUSIONS
 LITERATURE CITED
 
The glutamate-glutamine cycling flux in rat (Sibson et al. 1997 and 2001Citation Citation ) and human (Gruetter et al. 1998Citation , Shen et al. 1999Citation ) cortex is comparable in magnitude (~80%) to the corresponding rate of neuronal glucose oxidation and between 60 and 80% of total cerebral glucose oxidation. Because oxygen and glucose utilization rates (Hyder et al. 1996Citation , Siesjö 1978Citation , Sokoloff 1993Citation ) depend on neuronal activity, it follows that the glutamine synthesis rate should also depend on glucose oxidation rate to the extent that the former reflects glutamate-glutamine neurotransmitter cycling. Employing various anesthetic agents to produce different states of cortical electroencephalogram (EEG) activity and metabolism, Sibson et al. (1998a)Citation measured the rates of cortical glucose oxidation and glutamate-glutamine cycling using 13C NMR and [1-13C]glucose. Glutamate and glutamine isotopic turnovers were strongly dependent on cortical activity as reflected in the EEG. A plot of Vcycle against glucose oxidation [CMRglu(ox)] reveals a linear relationship with slope ~1.0 and y-intercept (where Vcycle = 0 and the cortex is electrically silent) of 0.1 µmol/(g · min) (Fig. 4Citation ). The rate of glutamine synthesis (and Vcycle) during EEG silence induced by high dose pentobarbital approaches the calculated theoretical value of NH3 transport into the brain [see discussion in Sibson et al. (1998b)Citation ]. The results suggest that >80% of neuronal glucose oxidation in the cerebral cortex is associated with the glutamate-glutamine cycle and neuronal activity.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 4. The relationship between the rates of glutamate-glutamine cycling (Vcycle) and glucose oxidation (CMRglu(ox)) is linear over a wide range of electrocortical activity in the rat cortex in vivo. Fluxes and electroencephalogram (EEG) activities were determined under conditions of pentobarbital (120 mg/kg, isoelectric EEG), {alpha}-chloralose (90 mg/kg, large amplitude EEG with slow waves), and morphine (50 mg/kg, faster desynchronized EEG rhythm). [From Sibson et al. (1998a)Citation , Copyright 1998 National Academy of Sciences, U.S.A., with permission.]

 
A possible explanation for these findings comes from studies of glutamate transport in cultured astrocytes. Glutamate uptake in cultured astrocytes has been shown to stimulate glucose utilization and lactate release in conjunction with the Na+-dependent activation of the plasma membrane Na+/K+-ATPase (Pellerin and Magistretti 1994Citation , Sokoloff et al. 1996Citation , Tsacopoulos and Magistretti 1996Citation ). On the basis of this evidence, Magistretti and co-workers proposed that "functional" glucose uptake occurs mainly in the astroglia in response to uptake of glutamate released from neurons and that lactic acid produced in the astroglia is transported to the neurons where it is oxidized. The flux stoichiometry between glucose oxidation and Vcycle of 1:1 reported by Sibson et al. (1998a)Citation both supports and extends the original proposal and provides a possible explanation for the observed stoichiometry. For example, the process of glutamate uptake into astroglia and its conversion to glutamine would require one ATP to restore the Na+ gradient (3 Na+ ions cotransported with glutamate) and a second ATP to produce glutamine from glutamate and ammonia via glutamine synthetase. Because glycolysis generates 2 molecules of ATP (net) per molecule of glucose converted to lactate, the predicted stoichiometry between glutamate-glutamine cycling and astroglial glucose utilization would be consistent with the experimental observations. These findings have important implications for the interpretation of neuroimaging signals as discussed by Shulman and Rothman (1998)Citation .


    CONCLUSIONS
 TOP
 ABSTRACT
 INTRODUCTION
 The glutamate-glutamine cycle:...
 Specialized transporters clear...
 Glutamine transporters mediate...
 In vivo NMR studies...
 Development of a quantitative...
 Measurements of glutamine...
 The rate of glutamine...
 CONCLUSIONS
 LITERATURE CITED
 
In vivo NMR studies support a tight linkage between glucose and glutamate neurotransmitter metabolism in the cerebral cortex. Studies have shown that the glutamate-glutamine cycle, in which neuronal glutamate is released by neurotransmission from the nerve terminal and taken up and converted to glutamine by the astrocyte, is a major pathway of glutamate and glutamine metabolism. In the conscious resting state, the rate of this pathway is comparable to the rate of cerebral glucose metabolism. At levels of electrical activity above isoelectricity, the rate of the glutamate-glutamine cycle and neuronal glucose oxidation increase in a 1:1 stoichiometry, strongly suggesting that these processes are coupled. The measured stoichiometry is consistent with the predictions of a model proposed by Magistretti and co-workers in which ATP produced by astroglial glycolysis fuels glutamate uptake.


    FOOTNOTES
 
1 Presented at the International Symposium on Glutamine, October 2–3, 2000, Sonesta Beach, Bermuda. The symposium was sponsored by Ajinomoto USA, Incorporated. The proceedings are published as a supplement to The Journal of Nutrition. Editors for the symposium publication were Douglas W. Wilmore, the Department of Surgery, Brigham and Women’s Hospital, Harvard Medical School and John L. Rombeau, the Department of Surgery, the University of Pennsylvania School of Medicine. Back

2 Supported by research grants from the National Institutes of Health NS34813, HD32573, NS32126 and DK27121. Back

4 Abbreviations used: CMRglu(ox), cerebral metabolic rate of glucose oxidation; EAAC, excitatory amino acid carrier; EAAT, excitatory amino acid transporter; EEG, electroencephalogram; GABA, {gamma}-aminobutyric acid; GABA-T, GABA transaminase; GAT, GABA transporter; GDH, glutamate dehydrogenase; GLT, glutamate transporter; GS, glutamine synthetase; NMR, nuclear magnetic resonance; PAG, phosphate-activated glutaminase; PC, pyruvate carboxylase; PDH, pyruvate dehydrogenase; TCA, tricarboxylic acid cycle; Vana, anaplerotic glutamine synthesis flux; VCO2, carbon dioxide fixation flux; Vcycle, glutamate-glutamine cycle flux; Vefflux, net ammonia transported out of the brain; Vgln, glutamine synthesis flux; VTCA, TCA cycle flux; Vtrans, net ammonia transported into the brain. Back


    LITERATURE CITED
 TOP
 ABSTRACT
 INTRODUCTION
 The glutamate-glutamine cycle:...
 Specialized transporters clear...
 Glutamine transporters mediate...
 In vivo NMR studies...
 Development of a quantitative...
 Measurements of glutamine...
 The rate of glutamine...
 CONCLUSIONS
 LITERATURE CITED
 

1. Arriza J. L., Eliasof S., Kavanaugh M. P. & Amara S. G. (1997) Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc. Natl. Acad. Sci. U.S.A. 94:4155-4160.[Abstract/Free Full Text]

2. Bachelard H. (1998) Landmarks in the application of 13C-magnetic resonance spectroscopy to studies of neuronal/glial relationships. Dev. Neurosci. 20:277-288.[Medline]

3. Badar-Goffer R. S, Bachelard H. S. & Morris P. G. (1990) Cerebral metabolism of acetate and glucose studied by 13C NMR spectroscopy: a technique for investigating metabolic compartmentation in the brain. Biochem. J. 266:133-139.[Medline]

4. Badar-Goffer R. S., Ben-Yoseph O., Bachelard H. S. & Morris P. G. (1992) Neuronal-glial metabolism under depolarizing conditions: a [13C]NMR study. Biochem. J. 282:225-230.

5. Balazs R., Machiyama Y. & Patel A. J. (1973) Balazs R. Cremer J. eds. Metabolic Compartmentation in the Brain 1973:57 Macmillan London, UK .

6. Bergles D. E. & Jahr C. E. (1997) Synaptic activation of glutamate transporters in hippocampal astrocytes. Neuron 19:1297-1308.[Medline]

7. Bergles D. E. & Jahr C. E. (1998) Glial contribution to glutamate uptake at Schaffer collateral-commissural synapses in the hippcampus. J. Neurosci. 18:7709-7716.[Abstract/Free Full Text]

8. Broer A., Brookes N., Ganapathy V., Dimmer K. S., Wagner C. A., Lang F. & Broer S. (1999) The astroglial ASCT2 amino acid transporter as a mediator of glutamine efflux. J. Neurochem. 73:2184-2194.[Medline]

9. Cerdán S., Kunnecke B. & Seelig J. (1990) Cerebral metabolism of (1,2-13C2) acetate as detected by in vivo and in vitro 13C NMR. J. Biol. Chem. 265:12916-12926.[Abstract/Free Full Text]

10. Chan-Palay V., Wu J.-Y. & Palay S. L. (1979) Immunocytochemical localization of {gamma}-aminobutyric acid transaminase at cellular and ultrastructural levels. Proc. Natl. Acad. Sci. U.S.A. 76:2067-2071.[Abstract/Free Full Text]

11. Chaudhry F. A., Lehre K. P., van Lookeren Campagne M., Ottersen O. P., Danbolt N. C. & Storm-Mathisen J. (1995) Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15:711-720.[Medline]

12. Chaudhry F. A., Reimer R. J., Krizaj D., Barber D., Storm-Mathisen J., Copenhagen D. R. & Edwards R. H. (1999) Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission. Cell 99:769-780.[Medline]

13. Chen C. J., Liao S. L. & Kuo J. S. (2000) Gliotoxic action of glutamate on cultured astrocytes. J. Neurochem. 75:1557-1565.[Medline]

14. Choi D. W., Maulucci-Gedde M. & Kriegstein A. R. (1987) Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7:357-368.[Abstract]

15. Conti F. & Minelli A. (1994) Glutamate immunoreactivity in rat cerebral cortex is reversibly abolished by 6-diazo-5-oxo-L-norleucine (DON), an inhibitor of phosphate-activated glutaminase. J. Histochem. Cytochem. 42:717-726.[Abstract]

16. Cooper A. J. & Plum F. (1987) Biochemistry and physiology of brain ammonia. Physiol. Rev. 67:440-519.[Free Full Text]

17. Cruz F. & Cerdán S. (1999) Quantitative 13C NMR studies of metabolic compartmentation in the adult mammalian brain. NMR Biomed 12:451-462.[Medline]

18. Cruz F., Scott S. R., Barroso I., Santisteban P. & Cerdán S. (1998) Ontogeny and cellular localization of the pyruvate recycling system in rat brain. J. Neurochem. 70:2613-2619.[Medline]

19. Dejong C. H., Kampman M. T., Deutz N. E. & Soeters P. B. (1992) Cerebral cortex ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat. J. Neurochem. 59:1071-1079.[Medline]

20. Fairman W. A., Vandenberg R. J., Arriza J. L., Kavanaugh M. P. & Amara S. G. (1995) An excitatory amino acid transporter with properties of a ligand-gated chloride channel. Nature (Lond.) 375:599-603.[Medline]

21. Fitzpatrick S. M., Hetherington H. P., Behar K. L. & Shulman R. G. (1990) The flux from glucose to glutamate in the rat brain in vivo as determined by 1H-observed, 13C-edited NMR spectroscopy. J. Cereb. Blood Flow Metab 10:170-179.[Medline]

22. Gruetter R., Novotny E. J., Boulware S. D., Mason G. F., Rothman D. L., Shulman G. I., Prichard J. W. & Shulman R. G. (1994) Localized 13C NMR spectroscopy in the human brain of amino acid labeling from [1-13C] D-glucose. J. Neurochem 63:1377-1385.[Medline]

23. Gruetter R., Seaquist E. R., Kim S. & Ugurbil K. (1998) Localized in vivo 13C-NMR of glutamate metabolism in the human brain: initial results at 4 tesla. Dev. Neurosci. 20:380-388.[Medline]

24. Haberg A., Qu H., Bakken I. J., Sande L. M., White L. R., Haraldseth O., Unsgard G., Aasly J. & Sonnewald U. (1998) In vitro and ex vivo 13C-NMR spectroscopy studies of pyruvate recycling in brain. Dev. Neurosci. 20:389-398.[Medline]

25. Henn F. A. & Hamberger A. (1971) Glial cell function: uptake of transmitter substances. Proc. Natl. Acad. Sci. U.S.A. 68:2686-2690.[Abstract/Free Full Text]

26. Hertz L., Wu P. H. & Schousboe A. (1978) Evidence for net uptake of GABA into mouse astrocytes in primary cultures: its sodium dependence and potassium independence. Neurochem. Res. 3:313-323.[Medline]

27. Hogstad S., Svenneby G., Torgner I. A., Kvamme E., Hertz L. & Schousboe A. (1988) Glutaminase in neurons and astrocytes cultured from mouse brain: kinetic properties and effects of phosphate, glutamate, and ammonia. Neurochem. Res. 13:383-388.[Medline]

28. Hyder F., Chase J. R., Behar K. L., Mason G. F., Siddeek M., Rothman D. L. & Shulman R. G. (1996) Increased tricarboxylic acid cycle flux in rat brain during forepaw stimulation detected with. 1H[13C] NMR. Proc. Natl. Acad. Sci. U.S.A. 93:7612-7617.[Abstract/Free Full Text]

29. Kanai Y. & Hediger M. A. (1992) Primary structure and functional characterization of a high affinity glutamate transporter. Nature (Lond.) 360:467-471.[Medline]

30. Kanamori K. & Ross B. D. (1993) 15N NMR measurement of the in vivo rate of glutamine synthesis and utilization at steady state in the brain of the hyperammonaemic rat. Biochem. J. 293:461-468.

31. Kanamori K. & Ross B. D. (1995) In vivo activity of glutaminase in the brain of hyperammonaemic rats measured in vivo by 15N nuclear magnetic resonance. Biochem. J. 305:329-336.

32. Kaufman E. E. & Driscoll B. F. (1993) Evidence for cooperativity between neurons and astroglia in the regulation of CO2 fixation in vitro. Dev. Neurosci. 15:299-305.[Medline]

33. Kvamme E. & Lenda K. (1982) Regulation of glutaminase by exogenous glutamate, ammonia and 2-oxoglutarate in synaptosomal enriched preparation from rat brain. Neurochem. Res 7:667-678.[Medline]

34. Larsson O. M. & Schousboe A. (1990) Kinetic characterization of GABA-transaminase from cultured neurons and astrocytes. Neurochem. Res. 15:1073-1077.[Medline]

35. Levy L. M., Warr O. & Attwell D. (1998) Stoichiometry of the glial glutamate transporter GLT-1 expressed inducibly in a Chinese hamster ovary cell line selected for low endogenous Na+-dependent glutamate uptake. J. Neurosci. 18:9620-9628.[Abstract/Free Full Text]

36. Martin D. L. (1995) The role of glia in the inactivation of neurotransmitters. Kettenmann H. Ransom B.R. eds. Neuroglia 1995:732-745 Oxford University Press New York, NY. .

37. Martinez-Hernandez A., Bell K. P. & Norenberg M. D. (1977) Glutamine synthetase: glial localization in brain. Science (Washington DC) 195:1356-1358.[Abstract/Free Full Text]

38. Mason G. F., Petersen K., Shen J., Behar K. L., Petroff O.A.C., Shulman G. I. & Rothman D. L. (2000) Measurement of the rate of pyruvate carboxylase in human brain by 13C NMR. Abst. Int. Soc. Magn. Reson. Med. 1:422(abs.).

39. McKenna M. C., Sonnewald U., Huang X., Stevenson J. & Zielke H. R. (1996) Exogenous glutamate concentration regulates the metabolic fate of glutamate in astrocytes. J. Neurochem. 66:386-393.[Medline]

40. McKenna M. C., Tildon J. T., Stevenson J. H., Huang X. & Kingwell K. G. (1995) Regulation of mitochondrial and cytosolic malic enzymes from cultured rat brain astrocytes. Neurochem. Res. 20:1491-1501.[Medline]

41. Minelli A., Brecha N. C., Karschin C., DeBiasi S. & Conti F. (1995) GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex. J. Neurosci. 15:7734-7746.[Abstract]

42. Minelli A., DeBiasi S., Brecha N. C., Zuccarello L. V. & Conti F. (1996) GAT-3, a high-affinity GABA plasma membrane transporter, is localized to astrocytic processes, and it is not confined to the vicinity of GABAergic synapses in the cerebral cortex. J. Neurosci. 16:6255-6264.[Abstract/Free Full Text]

43. Pascual J. M., Carceller F., Roda J. M. & Cerdán S. (1998) Glutamate, glutamine and GABA as substrates for the neuronal and glial compartments after focal cerebral ischemia in rats. Stroke 29:1048-1057.[Abstract/Free Full Text]

44. Patel A., Rothman D. L., Wang B. & Behar K. L. (2000) Glutamine is a significant precursor for GABA synthesis in the rat cortex following acute GABA-transaminase inhibition. Abst. Am. Soc. Neurochem., 31st Ann. Meeting, March 25–29, Chicago, IL 2000.

45. Pellerin L. & Magistretti P. J. (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc. Natl. Acad. Sci. U.S.A. 91:10625-10629.[Abstract/Free Full Text]

46. Peng L., Hertz L., Huang R., Sonnewald U., Petersen S. B., Westergaard N., Larsson O. & Schousboe A. (1993) Utilization of glutamine and TCA cycle constituents as precursors for transmitter glutamate and GABA. Dev. Neurosci 15:367-377.[Medline]

47. Ribak C. E., Tong W. M. & Brecha N. C. (1996) GABA plasma membrane transporters, GAT-1 and GAT-3, display different distributions in the rat hippocampus. J. Comp. Neurol. 367:595-606.[Medline]

48. Rothman D. L., Behar K. L., Hetherington H. P., den Hollander J. A., Bendall M. R., Petroff O. A. & Shulman R. G. (1985) 1H-Observe/13C-decouple spectroscopic measurements of lactate and glutamate in the rat brain in vivo. Proc. Natl. Acad. Sci. U.S.A. 82:1633-1637.[Abstract/Free Full Text]

49. Rothman D. L., Sibson N. R., Hyder F., Shen J., Behar K. L. & Shulman R. G. (1999) In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354:1165-1177.[Abstract/Free Full Text]

50. Rothstein J. D., Dykes-Hoberg M., Pardo C. A., Bristol L. A., Jin L., Kuncl R. W., Kanai Y., Hediger M. A., Wang Y., Schielke J. P. & Welty D. F. (1996) Knockout of glutamate transporters reveal a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-686.[Medline]

51. Rothstein J. D., Martin L., Levey A. I., Dykes-Hoberg M., Jin L., Wu D., Nash N. & Kuncl R. W. (1994) Localization of neuronal and glial transporters. Neuron 13:713-725.[Medline]

52. Ryan L. D. & Roskoski R., Jr (1977) Net uptake of gamma-aminobutyric acid by a high affinity synaptosomal transport system. J. Pharmacol. Exp. Ther. 200:285-291.[Abstract/Free Full Text]

53. Schousboe A., Westergaard N., Sonnewald U., Petersen S. B., Huang R., Peng L. & Hertz L. (1993) Glutamate and glutamine metabolism and compartmentation in astrocytes. Dev. Neurosci. 15:359-366.[Medline]

54. Sepkuty J. P., Behar K. L. & Rothstein J. D. (2000) Molecular knockdown of the glutamate transporter EAAC1 reduces new GABA synthesis in rat hippocampus 2000 Soc. Neurosci. Abstr New Orleans, LA. .

55. Shank R. P. & Campbell G. L. (1984) {alpha}-Ketoglutarate and malate uptake and metabolism by synaptosomes: further evidence for an astrocyte to neuron metabolic shuttle. J. Neurochem. 42:1153-1161.[Medline]

56. Shank R. P., Leo G. C. & Zielke H. R. (1993) Cerebral metabolic compartmentation as revealed by nuclear magnetic resonance analysis of D-[1-13C]glucose metabolism. J. Neurochem. 61:315-323.[Medline]

57. Shen J., Petersen K. F., Behar K. L., Brown P., Nixon T. W., Mason G., Petroff O.A.C., Shulman G. I., Shulman R. G. & Rothman D. L. (1999) Determination of the rate of the glutamate-glutamine cycle in the human brain by in vivo 13C NMR. Proc. Natl. Acad. Sci. U.S.A. 96:8235-8240.[Abstract/Free Full Text]

58. Shen J., Sibson N. R., Cline G., Behar K. L., Rothman D. L. & Shulman R. G. (1998) 15N NMR spectroscopy studies of ammonia transport and glutamine synthesis in the hyperammonemic rat brain. Dev. Neurosci. 20:434-443.[Medline]

59. Shulman R. G. & Rothman D. L. (1998) Interpreting functional imaging studies in terms of neurotransmitter cycling. Proc. Natl. Acad. Sci. U.S.A. 95:11993-11998.[Abstract/Free Full Text]

60. Sibson N. R., Dhankhar A., Mason G. F., Behar K. L., Rothman D. L. & Shulman R. G. (1997) In vivo 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling. Proc. Natl. Acad. Sci. U.S.A. 94:2699-2704.[Abstract/Free Full Text]

61. Sibson N. R., Dhankhar A., Mason G. F., Rothman D. L., Behar K. L. & Shulman R. G. (1998a) Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc. Natl. Acad. Sci. U.S.A. 95:316-321.[Abstract/Free Full Text]

62. Sibson N. R., Mason G. F., Shen J., Cline G. W., Herskovits A. Z., Wall J.E.M., Behar K. L., Rothman D. L. & Shulman R. G. (2001) In vivo 13C NMR measurement of neurotransmitter glutamate cycling, anaplerosis, and TCA cycle flux in rat brain during [2-13C]glucose infusion in rat brain. J. Neurochem. 76:975-989.[Medline]

63. Sibson N. R., Shen J., Mason G. F., Rothman D. L., Behar K. L. & Shulman R. G. (1998b) Functional energy metabolism: in vivo 13C-NMR spectroscopy evidence for coupling of cerebral glucose consumption and glutamatergic neuronal activity. Dev. Neurosci. 20:321-330.[Medline]

64. Siesjö B. K. (1978) Brain Energy Metabolism 1978 John Wiley & Sons New York, NY. .

65. Sokoloff L. (1993) Sites and mechanisms of function-related changes in energy metabolism in the nervous system. Dev. Neurosci. 15:194-206.[Medline]

66. Sokoloff L., Takahashi S., Gotoh J., Driscoll B. F. & Law M. J. (1996) Contribution of astroglia to functionally activated energy metabolism. Dev. Neurosci. 18:343-352.

67. Sonnewald U., Westergaard N., Schousboe A., Svendsen J. S., Unsgard G. & Petersen S. B. (1993) Direct demonstration by [13C]NMR spectroscopy that glutamine from astrocytes is a precursor for GABA synthesis in neurons. Neurochem. Int. 22:19-29.[Medline]

68. Szerb J. C. & O’Regan P. A. (1985) Effect of glutamine on glutamate release from hippocampal slices induced by high K+ or by electrical stimulation: interaction with different Ca2+ concentrations. J. Neurochem. 44:1724-1731.[Medline]

69. Tsacopoulos M. & Magistretti P. J. (1996) Metabolic coupling between glia and neurons. J. Neurosci. 16:877-885.[Free Full Text]

70. Van den Berg C. J. (1972) A model of compartmentation in mouse brain based on glucose and acetate metabolism. Balazs R. Cremer J.E. eds. Metabolic Compartmentation in the Brain 1972:137-166 John Wiley & Sons New York, NY. .

71. Varoqui H., Zhu H., Yao D., Ming H. & Erickson J. D. (2000) Cloning and functional identification of a neuronal glutamine transporter. J. Biol. Chem. 275:4049-4054.[Abstract/Free Full Text]

72. Vogel R., Wiesinger H., Hamprecht B. & Dringen R. (1999) The regeneration of reduced glutathione in rat forebrain mitochondria identifies metabolic pathways providing the NADPH required. Neurosci. Lett. 275:97-100.[Medline]

73. Waelsch H., Berl S., Rossi C. A., Clarke D. D. & Purpura D. P. (1964) Quantitative aspects of CO2 fixation in mammalian brain in vivo. J. Neurochem. 11:717-728.[Medline]

74. Wanienski R. A. & Martin D. L. (1986) Exogenous glutamate is metabolized to glutamine and exported by rat primary astrocyte cultures. J. Neurochem. 47:304-313.[Medline]

75. Ward H. K., Thanki C. M. & Bradford H. F. (1983) Glutamine and glucose as precursors of transmitter amino acids: ex vivo studies. J. Neurochem. 40:855-860.[Medline]

76. Westergaard N., Sonnewald U. & Schousboe A. (1995) Metabolic trafficking between neurons and astrocytes: the glutamate-glutamine cycle revisited. Dev. Neurosci. 17:203-211.[Medline]

77. Wiesinger H. (1995) Glia-specific enzyme systems. Kettenmann H. Ransom B. R. eds. Neuroglia 1995:488-499 Oxford University Press New York, NY. .

78. Yamada K., Watanabe M., Shibata T., Tanaka K., Wada K. & Inoue Y. (1996) EAAT4 is a post-synaptic glutamate transporter at Purkinje cell synapses. Neuroreport 7:2013-2017.[Medline]

79. Yao D., Mackenzie B., Ming H., Varoqui H., Zhu H., Hediger M. A. & Erickson J. D. (2000) A novel system A isoform mediating Na+/neutral amino acid cotransport. J. Biol. Chem. 275:22790-22797.[Abstract/Free Full Text]

80. Yu A.C.H., Schousboe A. & Hertz L. (1982) Metabolic fate of (14C)-labelled glutamate in astrocytes. J. Neurochem. 39:954-966.[Medline]

81. Yudkoff M. (1997) Brain metabolism of branched-chain amino acids. Glia 21:92-98.[Medline]




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
A. B. Patel, R. A. de Graaf, G. F. Mason, D. L. Rothman, R. G. Shulman, and K. L. Behar
The contribution of GABA to glutamate/glutamine cycling and energy metabolism in the rat cortex in vivo
PNAS, April 12, 2005; 102(15): 5588 - 5593.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
V. R. Young and A. M. Ajami
Glutamine: The Emperor or His Clothes?
J. Nutr., September 1, 2001; 131(9): 2449S - 2459.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Behar, K. L.
Right arrow Articles by Rothman, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Behar, K. L.
Right arrow Articles by Rothman, D. L.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2001 by American Society for Nutrition